A carregar...

Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Understanding the molecular defects underlying cardiovascular disease is necessary for the development of therapeutics. The most common method to lower circulating lipids, which reduces the incidence of cardiovascular disease, is statins, but other drugs are now entering the clinic, some of which ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biochim Biophys Acta
Main Authors: Doonan, Lynley M., Fisher, Edward A., Brodsky, Jeffrey L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5953829/
https://ncbi.nlm.nih.gov/pubmed/29627384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2018.03.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!